Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomised sequential trial of lithium in amyotrophic lateral sclerosis
2008-002110-22Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2008
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in amyotrophic lateral sclerosis (ALS) comparing Lithium carbonate + riluzole with Placebo + riluzole (2 arms). Primary endpoint: Survival. Started Aug 2008; status: completed.
02
Drugs
lithium carbonate
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2008-002110-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002110-22.